Invasive Fungal Infection

Area of Science:

• Infectious Diseases
• Mycology
• Critical Care Medicine

Background:

• Invasive fungal infections (IFIs) occur in approximately 6 per 100,000 individuals annually.
• IFIs are often undetected, contributing to mortality in intensive care units.
• Rising antifungal drug resistance poses a global health challenge.

Purpose of the Study:

• To review current guidelines for diagnosing and treating IFIs.
• To highlight key risk factors and treatment strategies for common fungal pathogens.
• To emphasize the need for improved detection and novel therapeutic approaches.

Main Methods:

• Selective PubMed search focusing on IFIs caused by Candida, Aspergillus, Mucorales, and Fusarium species.
• Review of pertinent publications and clinical guidelines.
• Consideration of diagnostic complexity involving clinical, radiological, and microbiological data.

Main Results:

• Key risk factors for IFIs include immunosuppression, granulocytopenia, and stem cell transplantation.
• First-line treatments involve echinocandins for candidemia and azoles for aspergillosis, guided by local epidemiology.
• Treatment decisions must account for drug side effects and interactions.

Conclusions:

• IFIs are underdiagnosed in hospital settings and require integration into antimicrobial stewardship programs.
• Development of new antifungal drug classes is urgently needed.
• Interdisciplinary collaboration is essential for managing IFIs effectively.